CAS RN: 155659-28-2
Ruthenium(2+), bis(2,2′-bipyridine-κN1,κN1′)(dipyrido[3,2-a:2′,3′-c]phenazine-κN4,κN5)-, dichloride
Product Availability
Choose a grade to view its available package options.
4 package records3 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251119 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250726 |
100mg / 250mg / 1g |
Out of stock |
| 8-10 business days | Inquiry |
| Batchno.20251228 |
1g |
In stock |
Shenzhen | | Inquiry |
| Batchno.20250904 |
250mg |
In stock |
Shenzhen, Tianjin, Wuhan, Chengdu | | Inquiry |
-
Product code:
starshine_CAS155659-28-2
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
155659-28-2 / bis(2-pyridin-2-ylpyridine);quinoxalino[2,3-f][1,10]phenanthroline;ruthenium(2+);dichloride
Standard CAS: 155659-28-2
Multi CAS: No
Basic Information
CAS
155659-28-2
Multi CAS
No
Molecular Formula
C38H26Cl2N8Ru
Molecular Weight
766.600000
Exact Mass
766.070089
SMILES
C1=CC=C2C(=C1)N=C3C4=C(C5=C(C3=N2)C=CC=N5)N=CC=C4.C1=CC=NC(=C1)C2=CC=CC=N2.C1=CC=NC(=C1)C2=CC=CC=N2.[Cl-].[Cl-].[Ru+2]
InChI
InChI=1S/C18H10N4.2C10H8N2.2ClH.Ru/c1-2-8-14-13(7-1)21-17-11-5-3-9-19-15(11)16-12(18(17)22-14)6-4-10-20-16;2*1-3-7-11-9(5-1)10-6-2-4-8-12-10;;;/h1-10H;2*1-8H;2*1H;/q;;;;;+2/p-2
InChIKey
CKTOYPUQYYMZGD-UHFFFAOYSA-L
Computed Properties
Structural Parameters
Heavy atom count
49
Aromatic heavy atom count
46
Rotatable bonds
2
H-bond acceptors
8
Molar refractivity
182.58
TPSA
103.12
LogP / Solubility
WLOGP
2.17
MLOGP
1.98
XLogP3
2.17
Consensus LogP
2.11
Log S (ESOL)
-6.52
Class (ESOL)
Insoluble
Log S (Ali)
-7.41
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-6.69
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-5.85
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.55
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
7